Insider Transactions in Q3 2024 at Neogenomics Inc (NEO)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2024
|
Alicia C Olivo General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,666
-3.8%
|
-
|
|
Aug 15
2024
|
Alicia C Olivo General Counsel |
SELL
Open market or private sale
|
Direct |
1,040
-2.32%
|
$16,640
$16.05 P/Share
|
|
Aug 15
2024
|
Christopher M Smith Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,130
-4.88%
|
-
|
|
Aug 10
2024
|
Anthony P. Zook Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,336
+50.0%
|
-
|
|
Aug 10
2024
|
David Brian Perez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,336
+34.38%
|
-
|
|
Aug 10
2024
|
Lynn A. Tetrault Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,336
+15.59%
|
-
|
|
Aug 10
2024
|
Michael Aaron Kelly Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,336
+26.31%
|
-
|
|
Aug 10
2024
|
Stephen M Kanovsky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,336
+23.9%
|
-
|
|
Aug 10
2024
|
Neil Gunn Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,336
+50.0%
|
-
|
|
Aug 10
2024
|
Alison L. Hannah Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,336
+8.71%
|
-
|
|
Aug 10
2024
|
Elizabeth Floegel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,336
+50.0%
|
-
|
|
Aug 01
2024
|
Alicia C Olivo General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
14
-0.03%
|
-
|